2025-04-27 - Analysis Report
## Rivian Automotive Inc. (RIVN) Stock Review

**0) Summary Statistics:**

Rivian Automotive Inc. (RIVN) is an American electric vehicle maker.  The stock has significantly underperformed the S&P 500 (VOO) over the period reviewed.  While recent price action shows some upward momentum, fundamental performance remains weak with negative earnings and profitability.


**1) Performance Comparison:**

* **Rivian Automotive Inc. (RIVN) Cumulative Return:** -33.36%
* **S&P 500 (VOO) Cumulative Return:** 14.92%
* **Performance Gap:** -48.3% (Relative Gap: 32.7%)  This means RIVN's underperformance relative to the S&P 500 is at the 32.7th percentile of its historical range of underperformance.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2021-2023  | -2.0% | 76.0% | -17.0% | 0.0 | 26.3 |
| 2022-2024  | 20.0% | 76.0% | -6.0% | 0.0 | 14.9 |
| 2023-2025  | 20.0% | 76.0% | -0.1 | 14.2 |

The negative alpha values consistently indicate underperformance compared to the benchmark.  Beta fluctuates suggesting market sensitivity changes over time.  The significant market cap reduction is noticeable.


**2) Recent Price Movement:**

* **Closing Price:** $12.62
* **5-Day Moving Average:** $11.80
* **20-Day Moving Average:** $11.81
* **60-Day Moving Average:** $11.99

The recent price of $12.62 shows a slight upward trend above the short-term moving averages, suggesting potential near-term positive momentum.  However, it remains below the 60-day average.  The substantial daily price change of 4.38% from the previous close indicates a sharp upward movement, suggesting potential market reaction to some news.


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.39 (Medium Risk)
* **RSI:** 64.6 (Slightly above neutral; not overbought)
* **PPO:** 0.75 (Positive; suggesting upward momentum)
* **20-Day Relative Divergence Change:** -2.0 (Short-term downward trend)
* **Expected Return:** -74.0% (Significant negative expected return relative to S&P 500 over the long term)

The technical indicators present a mixed picture. While the RSI and PPO suggest some positive momentum, the negative relative divergence and extremely low expected return raise concerns.


**4) Recent Earnings Analysis:**

| Date       | EPS      | Revenue     |
|------------|----------|-------------|
| 2024-11-07 | -$1.08   | $0.87 B     |
| 2024-08-06 | -$1.46   | $1.16 B     |
| 2024-05-07 | -$1.48   | $1.20 B     |
| 2023-11-07 | -$1.44   | $1.34 B     |
| 2024-11-07 | -$1.44   | $1.34 B     | *(Duplicate entry - likely an error)*

Consistent negative EPS demonstrates ongoing losses. While revenue fluctuates, it hasn't translated into profitability.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $1.73B | 9.80% |
| 2024-09-30 | $0.87B | -44.85% |
| 2024-06-30 | $1.16B | -38.95% |
| 2024-03-31 | $1.20B | -43.77% |
| 2023-12-31 | $1.31B | -46.08% |


**Capital and Profitability:**

| Quarter | Equity | ROE      |
|---------|---------|----------|
| 2024-12-31 | $6.56B | -11.33%  |
| 2024-09-30 | $5.90B | -18.65%  |
| 2024-06-30 | $6.82B | -21.37%  |
| 2024-03-31 | $8.07B | -17.92%  |
| 2023-12-31 | $9.14B | -16.64%  |

The financial data highlights significant losses and negative return on equity. While revenue increased in Q4 2024, the profit margin is still relatively low.  Equity has also decreased.

**6) Overall Analysis:**

Rivian is currently experiencing substantial financial challenges, reflected in consistent losses and negative profitability metrics. While recent price movements show short-term upward momentum,  the long-term outlook remains uncertain, given the negative expected return relative to the broader market and the company's struggles with sustained profitability.  The sharp daily price increase may be a temporary market fluctuation.  Investors should proceed with caution and carefully consider the company's fundamental weaknesses before making any investment decisions.  Further investigation into the causes of the recent price jump and the company's long-term growth strategy is warranted.
